Abstract
A multi-pronged approach to combating the COVID-19 pandemic in Kenya resulted in the formation of multidisciplinary research initiatives including genomic sequencing, syndromic surveillance, sero-surveillance, vaccination, and mathematical modelling. These initiatives generated an overwhelming amount of data that posed a challenge to researchers and public health officials, to effectively manage, analyse and promptly interpret for immediate pandemic response. As a result, there was demand for a platform to collate and integrate these datasets with interpretable findings to aid in pandemic management. In response, we developed a web-based dashboard, and integrated multidisciplinary datasets collected by the Ministry of Health-Kenya (MoH-K) and other research organizations, to support surveillance and monitoring of COVID-19 in Kenya. The developed dashboard combines genomics, epidemiological, seroprevalence, modelling, vaccination, syndromic and phylogenetic data and provides real-time updates to the public and health sector experts. The dashboard provides temporal trends of reported COVID-19 cases, fatalities, variants, and vaccination, in addition to summary reports from multiple cross-sectional seroprevalence studies and ongoing facility-based inpatient syndromic surveillance from 15 health facilities across Kenya. This is the first detailed interactive dashboard in Kenya that combines multiple datasets from a disease outbreak to provide valuable insights to researchers, health policy makers, the media and public not only during pandemic but also during routine surveillance. This resource is a model for digital platform for infectious disease surveillance and for informing public health planning and intervention.
Dashboard Link https://kcd.kemri-wellcome.org/
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by funds received from the UK Foreign Commonwealth and Development Office (FCDO) through the East Africa Research Fund and Wellcome Trust (grant 220985/Z/20/Z. This work is part of an integrated programme of SARS-CoV-2 sero-surveillance in Kenya led by KEMRI Wellcome Trust Research Programme.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Target Journal: BMC Public Health
Data Availability
Users who wish to access and use the data should send a request to the KEMRI Wellcome Trust Research Programme data governance committee, which can be contacted by emailing: dgc@kemri-wellcome.org.
